Welcome to our dedicated page for ALLSTATE SEC filings (Ticker: ALL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Allstate Corporation filings document the insurer's operating results, Regulation FD updates, governance matters and registered capital structure. Recent Form 8-K reports include quarterly and annual financial results, investor supplements, estimated catastrophe losses and policies in force for Allstate Protection.
Allstate's proxy materials describe board matters, executive compensation and shareholder voting items. Its filing cover pages identify common stock, fixed-to-floating subordinated debentures due 2053, and depositary shares representing Series H, Series I and Series J noncumulative preferred stock registered on public exchanges.
Richard T. Hume, a director of The Allstate Corporation (ALL), reported the conversion of 1,300 restricted stock units into 1,300 shares of common stock on 06/01/2025 under The Allstate Corporation 2017 Equity Compensation Plan for Non-Employee Directors. The conversion required no payment ($0) and increased his total beneficial ownership to 3,909 shares. The filing indicates the transaction code M and was signed on behalf of Mr. Hume by Meghan E. Jauhar as attorney-in-fact.
The Allstate Corporation filed a Form 8-K to share information under Regulation FD. The company states that its August 2025 monthly release, which announces estimated catastrophe losses and policies in force, has been posted on allstateinvestors.com and is included as Exhibit 99, a press release dated September 18, 2025. The exhibit is furnished rather than filed, meaning it is provided for informational purposes under the Regulation FD disclosure rules.
Suren Gupta, an officer of The Allstate Corporation (ALL), reported transactions on 09/06/2025 converting 13,898 previously awarded restricted stock units (RSUs) into 13,898 common shares under the 2019 Equity Incentive Plan without payment of consideration. After that conversion the filing shows 107,188 shares beneficially owned directly.
The filing also reports a sale of 6,157 shares on 09/06/2025 at an average price of $201.53, reducing direct ownership to 101,031 shares. Indirect holdings include 1,330 shares held via a 401(k) plan and 7 shares via VVG Holdings LLC. The Form 4 is signed by an attorney-in-fact and reflects routine equity compensation and an open-market disposition.
Thomas J. Wilson, Chairman, President & CEO of The Allstate Corporation (ALL), reported changes in indirect holdings of company stock options on August 22, 2025. The filing shows assignments among related trusts: the Thomas J. Wilson 2023-A GRAT Trust transferred 100% of membership interests in TJW Options LLC 2018 Series Last Third to the Thomas J. Wilson 2020 GRAT Remainder Trust and transferred 10.654% of membership interests in TJW Options LLC 2019 Series Middle Third to the same remainder trust. The Form 4 lists multiple employee stock options with exercise prices of $92.80 and $92.46, underlying common stock amounts shown at 75,802, 89,915, and other tranche balances. Some tranches show dispositions to zero while others remain indirectly owned by TJW Options LLC.
Mark Q. Prindiville, Executive Vice President & Chief Risk Officer of The Allstate Corporation (ALL), reported option exercise and multiple open-market sales on 08/22/2025. He exercised employee stock options to acquire 7,383 shares at an exercise price of $62.32 (options granted 02/11/2019, exercisable through 02/11/2026) and immediately sold a series of shares: 3,019 shares at a weighted average of $205.3347, 1,265 shares at $206.8183, 2,984 shares at $207.3099, and 115 shares at $208.2636. Following these transactions, he beneficially owned 22,274 shares directly and 0 shares indirectly, with an additional 0 shares held indirectly through a 401(k) plan noted as 0. The Form 4 was signed by an attorney-in-fact on 08/26/2025.
The Allstate Corporation filed a Form 144 notifying of a proposed sale of 7,383 common shares through Fidelity Brokerage Services, with an aggregate market value of $1,537,214.43, to be sold on 08/22/2025 on the NYSE. The securities are reported as acquired on 08/22/2025 and traceable to an option granted 02/11/2016; payment is listed as cash. The filer represents no undisclosed material adverse information about the issuer and indicates no securities sold in the past three months. This notice documents a planned insider sale consistent with Rule 144 disclosure requirements.
The Allstate Corporation filed a Form 8-K to furnish its July 2025 monthly release on estimated catastrophe losses and policies in force. The release is posted on allstateinvestors.com and is also attached as Exhibit 99 to the report, which is incorporated by reference. The company notes that this exhibit is furnished, rather than filed, under Regulation FD, which affects how it is treated under securities laws but still makes the information broadly available to the market.